Skip to main content
Clinical Trials/ACTRN12617001650381
ACTRN12617001650381
Recruiting
Not Applicable

Role of home telemonitoring of lung function using the forced oscillation technique in predicting exacerbations and control among moderate-severe asthmatics during down-titration of treatment: a pragmatic, observational study

Woolcock Institute of Medical Research0 sites40 target enrollmentDecember 22, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Woolcock Institute of Medical Research
Enrollment
40
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2017
End Date
TBD
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria:
  • above 18 years of age,
  • diagnosis of asthma, confirmed by written report from a physician, and
  • receiving maintenance asthma treatment at at least Step 4 (on moderate to high dose of ICS (budesonide \>500 mcg/day or fluticasone propionate \>200 mcg/day or equivalent and LABA treatment) of Australian guidelines, and
  • ACQ\-5 score \<1\.5, consistent with adequate symptom control,
  • All patients will be eligible if their physician is considering stepping down their treatment, from step 4 (the most commonly prescribed asthma treatment in Australia) to step 3, by reducing their regular maintenance inhaled corticosteroid (ICS) dose by 50%, as recommended by Australian guidelines (see http://www.asthmahandbook.org.au/management/adults/stepped\-adjustment/stepping\-down).

Exclusion Criteria

  • any other confounding major disease or condition as deemed appropriate by investigator, determined by review of medical history and/or patient reported medical history, and
  • impaired ability to understand instructions or perform FOT unsupervised.

Outcomes

Primary Outcomes

Not specified

Similar Trials